Clinical Trials Browser

Completed × Interventional × Advanced Malignancy × Clear all

NCT03875157 2023-02-27

Study of IBI318 in Participants With Advanced Malignancies

Phase 1 Completed

Advanced Malignancy

NCT02978482 2021-08-18

A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies

Phase 1 Completed

Advanced Malignancy

NCT04216082 2020-01-02

A Study of Anlotinib in Subjects With Advanced Malignancy

Phase 2 Completed

Advanced Malignancy